Immunomodulation by atorvastatin upregulates expression of gap junction proteins in coxsackievirus B3 (CVB3)-induced myocarditis

Inflammation Research

Volumn 59, Issue 4, 2010, Pages 255-262

  Zhang, Alian ^a   Zhang, Huili ^a   Wu, Shiyao ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Atorvastatin; Connexin; Inflammation; Viral myocarditis

Indexed keywords

ATORVASTATIN; CONNEXIN 43; CONNEXIN 45; GAMMA INTERFERON; GAP JUNCTION PROTEIN; SODIUM CHLORIDE; TUMOR NECROSIS FACTOR ALPHA; CYTOKINE; HEPTANOIC ACID DERIVATIVE; IMMUNOLOGIC FACTOR; MESSENGER RNA; PYRROLE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; COXSACKIE VIRUS B; DOWN REGULATION; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; IMMUNOMODULATION; MALE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SURVIVAL RATE; UPREGULATION; VIRUS MYOCARDITIS; ANIMAL; BIOSYNTHESIS; COXSACKIE VIRUS INFECTION; GENETICS; METABOLISM; MYOCARDITIS; PATHOLOGY; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; CONNEXIN 43; CONNEXINS; COXSACKIEVIRUS INFECTIONS; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; HEPTANOIC ACIDS; IMMUNOHISTOCHEMISTRY; IMMUNOLOGIC FACTORS; INTERFERON-GAMMA; MICE; MYOCARDITIS; PYRROLES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 77953042905     PISSN: 10233830     EISSN: 1420908X     Source Type: Journal    
DOI: 10.1007/s00011-009-0093-8     Document Type: Article

References (35)

1. Kumar NM, Gilula NB. The gap junction communication channel. Cell. 1996;84:381-388
2. Desplantez T, Dupont E, Severs NJ, Weingart R. Gap junction channels and cardiac impulse propagation. J Membr Biol. 2007;218:13-28.
3. Coppen SR, Kodama I, Boyett MR, Dobrzynski H, Takagishi Y, Honjo H, et al. Connexin45, a major connexin of the rabbit sin-oatrial node, is coexpressed with connexin43 in a restricted zone at the nodal-crista terminalis border. J Histochem Cytochem. 1999;47:907-918
4. Severs NJ, Rothery S, Dupont E, Coppen SR, Yeh HI, Ko YS, et al. Immunocytochemical analysis of connexin expression in the healthy and diseased cardiovascular system. Microsc Res Tech. 2001;52:301-322
5. Severs NJ, Coppen SR, Dupont E, Yeh HI, Ko YS, Matsushita T. Gap junction alterations in human cardiac disease. Cardiovasc Res. 2004;62:368-377
6. Woodruff JF. Viral myocarditis: a review. Am J Pathol. 1980;101:425-484
7. Haas GJ. Etiology, evaluation, and management of acute myocarditis. Cardiol Rev. 2001;9:88-95.
8. Celes MR, Torres-Dueñas D, Alves-Filho JC, Duarte DB, Cunha FQ, Rossi MA. Reduction of gap and adherens junction proteins and intercalated disc structural remodeling in the hearts of mice submitted to severe cecal ligation and puncture sepsis. Crit Care Med. 2007;35:2176-2185
9. Fernandez-Cobo M, Gingalewski C, Drujan D, De Maio A. Downregulation of connexin 43 gene expression in rat heart during inflammation. The role of tumor necrosis factor. Cytokine. 1999;11:216-224
10. Sawaya SE, Rajawat YS, Rami TG, Szalai G, Price RL, Sivasubramanian N, et al. Downregulation of connexin 40 and increased prevalence of atrial arrhythmias in transgenic mice with cardiac-restricted overexpression of tumor necrosis factor. Am J Physiol Heart Circ Physiol. 2007;292:H1561-7.
11. Woodruff JF, Woodruff JJ. Involvement of T lymphocytes in the pathogenesis of coxsackie virus B3 heart disease. J Immunol. 1974;113:1723-1726
12. Fuse K, Chan G, Liu Y, Gudgeon P, Husain M, Chen M, et al. Myeloid differentiation factor-88 plays a crucial role in the pathogenesis of coxsackievirus B3-induced myocarditis and influences type I interferon production. Circulation. 2005;112:2276-2285
13. Kishimoto C, Kuribayashi K, Masuda T, Tomioka N, Kawai C. Immunologic behavior of lymphocytes in experimental viral myocarditis: significance of T lymphocytes in the severity of myocarditis and silent myocarditis in BALB/c-nu/nu mice. Circulation. 1985;71:1247-1254 (Pubitemid 15036372)
14. Kwak B, Mulhaupt F, Myit S, Mach F. Statins as a newly recognized type of immunomodulator. Nat Med. 2000;6:1399-1402
15. Weitz-Schmidt G, Welzenbach K, Brinkmann V, Kamata T, Kallen J, Bruns C, et al. Statins selectively inhibit leukocyte function antigen-1 by binding to a novel regulatory integrin site. Nat Med. 2001;7:687-692
16. Tribulová N, Knezl V, Okruhlicová L, Slezák J. Myocardial gap junctions: targets for novel approaches in the prevention of life-threatening cardiac arrhythmias. Physiol Res. 2008;57(Suppl 2):S1-13.
17. Simon AM, Goodenough DA. Diverse functions of vertebrate gap junctions. Trends Cell Biol. 1998;8:477-483
18. Kirchhoff S, Nelles E, Hagendorff A, Kruger O, Traub O, Willecke K. Reduced cardiac conduction velocity and predisposition to arrhythmias in connexin 40-deficient mice. Curr Biol. 1998;8:299-302.
19. Hagendorff A, Schumacher B, Kirchhoff S, Luderitz B, Willecke K. Conduction disturbances and increased atrial vulnerability in connexin40-deficient mice analyzed by transesophageal stimulation. Circulation. 1999;99:1508-1515
20. Hu VW, Xie HQ. Interleukin-1a suppresses gap junction mediated intercellular communication in human endothelial cells. Exp Cell Res. 1994;213:218-223
21. Van Rijen HV, van Kempen MJ, Postma S, Jongsma HJ. Tumour necrosis factor-a alters the expression of connexin 43, connexin 40, and connexin 37 in human umbilical vein endothelial cells. Cytokine. 1998;10:258-264
22. Mensink A, de Haan LH, Lakemond CM, Koelman CA, Koeman JH. Inhibition of gap junctional intercellular communication between primary human smooth muscle cells by tumor necrosis factor-a. Carcinogenesis. 1995;16:2063-2067
23. Chandross KJ. Nerve injury and inflammatory cytokines modulate gap junctions in the peripheral nervous system. Glia. 1998;24:21-31.
24. Bolanos JP, Medina JM. Induction of nitric oxide synthase inhibits gap junction permeability in cultured rat astrocytes. J Neurochem. 1996;66:2091-2099
25. Temme A, Traub O, Willecke K. Downregulation of connexin32 protein and gap-junctional intercellular communication by cyto-kine mediated acute-phase response in immortalized mouse hepatocytes. Cell Tissue Res. 1998;294:345-350
26. Fernandez-Cobo M, Gingalewski C, De Maio A. Expression of the connexin 43 gene is increased in the kidneys and the lungs of rats injected with bacterial lipopolysaccharide. Shock. 1998;10:97-102.
27. Fernandez-Cobo M, Stewart D, Drujan D, De Maio A. Promoter activity of the rat connexin 43 gene in NRK cells. J Cell Bio-chem. 2001;81:514-522
28. Gingalewski C, Wang K, Clemens MG, De Maio A. Posttrans-lational regulation of connexin32 expression in liver during acute inflammation. J Cell Physiol. 1996;166:461-467
29. De Maio A, Gingalewski C, Theodorakis NG, Clemens MG. Interruption of hepatic gap junctional communication in the rat during inflammation induced by bacterial lipopolysaccharide. Shock. 2000;14:53-59
30. Theodorakis NG, De Maio A. Cx32 mRNA in rat liver: effects of inflammation on poly(A) tail distribution and mRNA degradation. Am J Physiol. 1999;276:R1249-57.
31. Derouette JP, Roth I, Foglia B, Scerri I, Dudez T, Kwak BR, et al. Gap junctional communication in tissue inflammation and repair. Biochim Biophys Acta. 2005;1711:197-207.
32. Azuma RW, Suzuki J, Ogawa M, Futamatsu H, Koga N, Onai Y, et al. HMG-CoA reductase inhibitor attenuates experimental autoimmune myocarditis through inhibition of T cell activation. Cardiovasc Res. 2004;64:412-420
33. Liu W, Li WM, Gao C, Sun NL. Effects of atorvastatin on the Th1/Th2 polarization of ongoing experimental autoimmune myocarditis in Lewis rats. J Autoimmun. 2005;25:258-263
34. Li WM, Liu W, Gao C, Zhou BG. Immunoregulatory effects of atorvastatin on experimental autoimmune myocarditis in Lewis rats. Immunol Cell Biol. 2006;84:274-280
35. Wu JL, Matsui S, Zong ZP, Nishikawa K, Sun BG, Katsuda S, et al. Amelioration of myocarditis by statin through inhibiting cross-talk between antigen presenting cells and lymphocytes in rats. J Mol Cell Cardiol. 2008;44:1023-1031